中国临床新医学
中國臨床新醫學
중국림상신의학
Chinese Journal of New Clinical Medicine
2015年
11期
1049-1051
,共3页
噻托溴铵%信必可都保%慢性阻塞性肺疾病
噻託溴銨%信必可都保%慢性阻塞性肺疾病
새탁추안%신필가도보%만성조새성폐질병
Tiotropium bromide%Symbicort turbuhale%COPD
目的:观察噻托溴铵联合信必可都保治疗稳定期慢性阻塞性肺疾病( COPD)的效果。方法将100例稳定期COPD患者按入院顺序半随机分为观察组和对照组,每组50例。对照组给予茶碱缓释片常规口服,必要时给予沙丁胺醇气雾剂雾化治疗;观察组给予噻托溴铵联合信必可都保雾化治疗,连续治疗2个月。观察两组患者治疗前后肺功能及血气变化情况。结果观察组患者肺功能改善情况及血氧饱和情况明显优于对照组,且均具有统计学意义( P<0.05)。结论噻托溴铵联合信必可都保可明显改善稳定期COPD患者的肺功能状态,有利于改善患者预后,提高生活质量。
目的:觀察噻託溴銨聯閤信必可都保治療穩定期慢性阻塞性肺疾病( COPD)的效果。方法將100例穩定期COPD患者按入院順序半隨機分為觀察組和對照組,每組50例。對照組給予茶堿緩釋片常規口服,必要時給予沙丁胺醇氣霧劑霧化治療;觀察組給予噻託溴銨聯閤信必可都保霧化治療,連續治療2箇月。觀察兩組患者治療前後肺功能及血氣變化情況。結果觀察組患者肺功能改善情況及血氧飽和情況明顯優于對照組,且均具有統計學意義( P<0.05)。結論噻託溴銨聯閤信必可都保可明顯改善穩定期COPD患者的肺功能狀態,有利于改善患者預後,提高生活質量。
목적:관찰새탁추안연합신필가도보치료은정기만성조새성폐질병( COPD)적효과。방법장100례은정기COPD환자안입원순서반수궤분위관찰조화대조조,매조50례。대조조급여다감완석편상규구복,필요시급여사정알순기무제무화치료;관찰조급여새탁추안연합신필가도보무화치료,련속치료2개월。관찰량조환자치료전후폐공능급혈기변화정황。결과관찰조환자폐공능개선정황급혈양포화정황명현우우대조조,차균구유통계학의의( P<0.05)。결론새탁추안연합신필가도보가명현개선은정기COPD환자적폐공능상태,유리우개선환자예후,제고생활질량。
Objective To explore the curative effect of Tiotropium bromide combined with Symbicort turbu-haler on patients with stable COPD.Methods One hundred patients with stable COPD were randomly divided into the observation group and the control group.The control group was given theophylline orally, and if necessary salbu-tamol aerosol atomization treatment was given.The observation group was given Tiotropium bromide and Symbicort turbuhale therapy.For two consecutive months after the treatment, the changes of lung function and blood gas were analyzed and compared between the two groups.Results Lung function and blood oxygen saturation improved better in the observation group than those in the control group(P<0.05).Conclusion Tiotropium bromide combined with symbicort turbuhale can obviously improve the stability state of pulmonary function in COPD patients and improve the prognosis of patients and the quality of life.